Literature DB >> 22090119

High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections.

Khoa T D Thai1, Matthew R Henn, Michael C Zody, Vianney Tricou, Nguyen Minh Nguyet, Patrick Charlebois, Niall J Lennon, Lisa Green, Peter J de Vries, Tran Tinh Hien, Jeremy Farrar, H Rogier van Doorn, Menno D de Jong, Bruce W Birren, Edward C Holmes, Cameron P Simmons.   

Abstract

Little is known about the rate at which genetic variation is generated within intrahost populations of dengue virus (DENV) and what implications this diversity has for dengue pathogenesis, disease severity, and host immunity. Previous studies of intrahost DENV variation have used a low frequency of sampling and/or experimental methods that do not fully account for errors generated through amplification and sequencing of viral RNAs. We investigated the extent and pattern of genetic diversity in sequence data in domain III (DIII) of the envelope (E) gene in serial plasma samples (n = 49) taken from 17 patients infected with DENV type 1 (DENV-1), totaling some 8,458 clones. Statistically rigorous approaches were employed to account for artifactual variants resulting from amplification and sequencing, which we suggest have played a major role in previous studies of intrahost genetic variation. Accordingly, nucleotide sequence diversities of viral populations were very low, with conservative estimates of the average levels of genetic diversity ranging from 0 to 0.0013. Despite such sequence conservation, we observed clear evidence for mixed infection, with the presence of multiple phylogenetically distinct lineages present within the same host, while the presence of stop codon mutations in some samples suggests the action of complementation. In contrast to some previous studies we observed no relationship between the extent and pattern of DENV-1 genetic diversity and disease severity, immune status, or level of viremia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090119      PMCID: PMC3255838          DOI: 10.1128/JVI.05985-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies.

Authors:  Wei-Kung Wang; Su-Ru Lin; Chao-Min Lee; Chwan-Chuen King; Shan-Chwen Chang
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

3.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

4.  Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia.

Authors:  B Murgue; C Roche; E Chungue; X Deparis
Journal:  J Med Virol       Date:  2000-04       Impact factor: 2.327

5.  Dengue virus circulation and evolution in Mexico: a phylogenetic perspective.

Authors:  Francisco J Díaz; William C Black; José A Farfán-Ale; María A Loroño-Pino; Kenneth E Olson; Barry J Beaty
Journal:  Arch Med Res       Date:  2006-08       Impact factor: 2.235

6.  Phylogenetic evidence for recombination in dengue virus.

Authors:  E C Holmes; M Worobey; A Rambaut
Journal:  Mol Biol Evol       Date:  1999-03       Impact factor: 16.240

7.  Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system.

Authors:  T Laue; P Emmerich; H Schmitz
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

8.  From RNA to quasispecies: a DNA polymerase with proofreading activity is highly recommended for accurate assessment of viral diversity.

Authors:  Isabelle Malet; Magali Belnard; Henri Agut; Annie Cahour
Journal:  J Virol Methods       Date:  2003-05       Impact factor: 2.014

9.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

10.  An in-depth analysis of original antigenic sin in dengue virus infection.

Authors:  Claire M Midgley; Martha Bajwa-Joseph; Sirijitt Vasanawathana; Wannee Limpitikul; Bridget Wills; Aleksandra Flanagan; Emily Waiyaiya; Hai Bac Tran; Alison E Cowper; Pojchong Chotiyarnwong; Pojchong Chotiyarnwon; Jonathan M Grimes; Sutee Yoksan; Prida Malasit; Cameron P Simmons; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

View more
  30 in total

1.  Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity.

Authors:  Poornima Parameswaran; Patrick Charlebois; Yolanda Tellez; Andrea Nunez; Elizabeth M Ryan; Christine M Malboeuf; Joshua Z Levin; Niall J Lennon; Angel Balmaseda; Eva Harris; Matthew R Henn
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Costs and benefits of mutational robustness in RNA viruses.

Authors:  Adi Stern; Simone Bianco; Ming Te Yeh; Caroline Wright; Kristin Butcher; Chao Tang; Rasmus Nielsen; Raul Andino
Journal:  Cell Rep       Date:  2014-08-07       Impact factor: 9.423

3.  Increased replicative fitness of a dengue virus 2 clade in native mosquitoes: potential contribution to a clade replacement event in Nicaragua.

Authors:  Claire A Quiner; Poornima Parameswaran; Alexander T Ciota; Dylan J Ehrbar; Brittany L Dodson; Sondra Schlesinger; Laura D Kramer; Eva Harris
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

Review 4.  Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease.

Authors:  Lark L Coffey; Naomi Forrester; Konstantin Tsetsarkin; Nikos Vasilakis; Scott C Weaver
Journal:  Future Microbiol       Date:  2013-02       Impact factor: 3.165

5.  Large-scale sequencing and the natural history of model human RNA viruses.

Authors:  Vivien G Dugan; Kazima Saira; Elodie Ghedin
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

6.  De novo assembly of highly diverse viral populations.

Authors:  Xiao Yang; Patrick Charlebois; Sante Gnerre; Matthew G Coole; Niall J Lennon; Joshua Z Levin; James Qu; Elizabeth M Ryan; Michael C Zody; Matthew R Henn
Journal:  BMC Genomics       Date:  2012-09-13       Impact factor: 3.969

7.  LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets.

Authors:  Andreas Wilm; Pauline Poh Kim Aw; Denis Bertrand; Grace Hui Ting Yeo; Swee Hoe Ong; Chang Hua Wong; Chiea Chuen Khor; Rosemary Petric; Martin Lloyd Hibberd; Niranjan Nagarajan
Journal:  Nucleic Acids Res       Date:  2012-10-12       Impact factor: 16.971

8.  Transmission of equine influenza virus during an outbreak is characterized by frequent mixed infections and loose transmission bottlenecks.

Authors:  Joseph Hughes; Richard C Allen; Marc Baguelin; Katie Hampson; Gregory J Baillie; Debra Elton; J Richard Newton; Paul Kellam; James L N Wood; Edward C Holmes; Pablo R Murcia
Journal:  PLoS Pathog       Date:  2012-12-20       Impact factor: 6.823

9.  Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses.

Authors:  Jesse J Waggoner; Janaki Abeynayake; Malaya K Sahoo; Lionel Gresh; Yolanda Tellez; Karla Gonzalez; Gabriela Ballesteros; Anna M Pierro; Paolo Gaibani; Frances P Guo; Vittorio Sambri; Angel Balmaseda; Kumudu Karunaratne; Eva Harris; Benjamin A Pinsky
Journal:  PLoS Negl Trop Dis       Date:  2013-04-18

10.  Phylodynamic analysis of the emergence and epidemiological impact of transmissible defective dengue viruses.

Authors:  Ruian Ke; John Aaskov; Edward C Holmes; James O Lloyd-Smith
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.